Funders

LEAD SUPPORTER (2023-2024)

 

 

 

UCB is - as a global biopharmaceutical leader - focused on creating valuable solutions that make improvements to the lives of people living with neurological and autoimmune conditions now and into the future.
UCB continually innovate for patients connecting science in new ways –  chemistry, biology and gene therapy to leverage the potential of these disciplines. UCB is dedicated to improving the quality of life for people living with severe chronic diseases, including those with conditions such as Hidradenitis Suppurativa.